Bristol Myers Squibb said it will merge parts of its R&D operation under Cristian Massacesi, the company’s chief medical officer and head of development work, while Robert Plenge is stepping away from the head-of-research role. The change reshuffles leadership responsibilities as BMS continues to execute its pipeline strategy and organizational redesign.